-+ 0.00%
-+ 0.00%
-+ 0.00%

ASTELLAS DOSES FIRST PATIENT IN PHASE 3 STUDY OF SETIDEGRASIB IN PREVIOUSLY TREATED KRAS G12D-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER

Reuters·09/23/2026 23:30:01

Please log in to view news